Logotipo do repositório
 

Publicação:
Exploiting supramolecular interactions to produce bevacizumab-loaded nanoparticles for potential mucosal delivery

dc.contributor.authorFerreira, Leonardo M.B. [UNESP]
dc.contributor.authorAlonso, Jovan D. [UNESP]
dc.contributor.authorKiill, Charlene P. [UNESP]
dc.contributor.authorFerreira, Natália N. [UNESP]
dc.contributor.authorBuzzá, Hilde H.
dc.contributor.authorMartins de Godoi, Denis R. [UNESP]
dc.contributor.authorde Britto, Douglas
dc.contributor.authorAssis, Odilio Benedito G.
dc.contributor.authorSeraphim, Thiago V.
dc.contributor.authorBorges, Júlio César
dc.contributor.authorGremião, Maria Palmira D. [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionEmpresa Brasileira de Pesquisa Agropecuária (EMBRAPA)
dc.date.accessioned2018-12-11T16:52:56Z
dc.date.available2018-12-11T16:52:56Z
dc.date.issued2018-06-01
dc.description.abstractMonoclonal antibody (mAb) delivery is gaining importance for local, systemic, and route-specific targeting. The mucus constitutes the main barrier for this type of delivery. In the present study, we aimed to develop a drug delivery platform by integrating mucus penetrating and mucoadhesive agents into a single system. Our hypothesis is that by combining these opposing functions, this system could have its properties modulated according to specific purposes. Self-assembly studies were conducted using three classes of building blocks: the protein drug bevacizumab (BVZ), mucus-penetrating polyanion dextran sulfate (DS), mucoadhesive polycations trimethylchitosan (TMC) and chitosan oligosaccharides (COS). We obtained two types of nanoparticles by manipulating supramolecular interactions between the components. Binary protein-polyanion (BVZ/DS) nanoparticles showed size of approximately 150 nm and a negative zeta potential. Ternary protein-polyanion-polycation (BVZ/DS/COS) nanoparticles were obtained using COS and exhibited 350 nm and a positive zeta potential. Assisted by calorimetric information, we demonstrated that building stable ternary nanoparticles carrying positive charges were not possible using the polycation TMC due to its thermodynamic constraints. Furthermore, spectroscopy analysis and CAM assay indicated that BVZ continued structurally and functionally stable after its incorporation into the nanoparticles. These two types of nanoparticles exhibited different behaviors when interacting with mucin, as shown by DLS and AFM studies. While the negatively charged particles promoted dispersion of the mucin network, suggesting a mucus penetrating effect of DS, the positively charged particles formed aggregates, probably caused by the mucoadhesive effect of COS. These results highlight the importance of understanding the role of supramolecular interactions, responsible for forming drug delivery systems containing complex molecules, such as proteins and polymers.en
dc.description.affiliationSchool of Pharmaceutical Science São Paulo State University UNESP, Rodovia Araraquara/Jaú Km 1
dc.description.affiliationInstitute of Chemistry of Araraquara São Paulo State University UNESP
dc.description.affiliationBiophotonics Laboratory São Carlos Institute of Physics University of São Paulo (USP)
dc.description.affiliationEMBRAPA, Semi-Arid, Rodovia BE-428, Km 152, P.O. Box 23
dc.description.affiliationEMBRAPA Instrumentation Rua XV de Novembro, 1.452, P.O. Box 741
dc.description.affiliationInstitute of Chemistry of São Carlos University of São Paulo USP
dc.description.affiliationUnespSchool of Pharmaceutical Science São Paulo State University UNESP, Rodovia Araraquara/Jaú Km 1
dc.description.affiliationUnespInstitute of Chemistry of Araraquara São Paulo State University UNESP
dc.format.extent238-250
dc.identifierhttp://dx.doi.org/10.1016/j.eurpolymj.2018.04.013
dc.identifier.citationEuropean Polymer Journal, v. 103, p. 238-250.
dc.identifier.doi10.1016/j.eurpolymj.2018.04.013
dc.identifier.file2-s2.0-85045762083.pdf
dc.identifier.issn0014-3057
dc.identifier.scopus2-s2.0-85045762083
dc.identifier.urihttp://hdl.handle.net/11449/170919
dc.language.isoeng
dc.relation.ispartofEuropean Polymer Journal
dc.relation.ispartofsjr0,996
dc.rights.accessRightsAcesso abertopt
dc.sourceScopus
dc.subjectBevacizumab
dc.subjectDrug delivery platform
dc.subjectMucoadhesion
dc.subjectMucus penetration
dc.subjectPolymeric nanoparticles
dc.subjectSupramolecular interactions
dc.titleExploiting supramolecular interactions to produce bevacizumab-loaded nanoparticles for potential mucosal deliveryen
dc.typeArtigopt
dspace.entity.typePublication
relation.isOrgUnitOfPublication95697b0b-8977-4af6-88d5-c29c80b5ee92
relation.isOrgUnitOfPublication.latestForDiscovery95697b0b-8977-4af6-88d5-c29c80b5ee92
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt
unesp.campusUniversidade Estadual Paulista (UNESP), Instituto de Química, Araraquarapt

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
2-s2.0-85045762083.pdf
Tamanho:
2.89 MB
Formato:
Adobe Portable Document Format
Descrição: